Amyloid beta-protein1-42 increases cAMP and apolipoprotein E levels which are inhibited by β1 and β2-adrenergic receptor antagonists in mouse primary astrocytes

U. Igbavboa, L. N. Johnson-Anuna, X. Rossello, T. A. Butterick, G. Y. Sun, W. Gibson Wood

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Amyloid beta-protein1-42 increases cAMP and apolipoprotein E levels which are inhibited by β1 and β2-adrenergic receptor antagonists in mouse primary astrocytes'. Together they form a unique fingerprint.

Medicine & Life Sciences